
### [NCIT:C3242](http://purl.obolibrary.org/obo/NCIT_C3242)
**Label:** Plasma Cell Myeloma

**Subclasses:** [NCIT:C4734](http://purl.obolibrary.org/obo/NCIT_C4734) (Non-Secretory Plasma Cell Myeloma), [NCIT:C7765](http://purl.obolibrary.org/obo/NCIT_C7765) (Osteosclerotic Plasma Cell Myeloma), [NCIT:C7149](http://purl.obolibrary.org/obo/NCIT_C7149) (Smoldering Plasma Cell Myeloma), [NCIT:C7242](http://purl.obolibrary.org/obo/NCIT_C7242) (Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder), 

**Class expressions from DL-Learner:**

- [NCIT:C41032](http://purl.obolibrary.org/obo/NCIT_C41032) (Bone Marrow-Homing Plasma Cell) 62.50%
- Thing 52.03%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38997](http://purl.obolibrary.org/obo/NCIT_C38997) (Cancer Susceptibility Pathway))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38996](http://purl.obolibrary.org/obo/NCIT_C38996) (ATM Signaling Pathway))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38995](http://purl.obolibrary.org/obo/NCIT_C38995) (Angiotensin II Signaling Pathway))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38992](http://purl.obolibrary.org/obo/NCIT_C38992) (Ribosomal Biogenesis Pathway))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38981](http://purl.obolibrary.org/obo/NCIT_C38981) (AKT Signaling Pathway))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38975](http://purl.obolibrary.org/obo/NCIT_C38975) (Agrin Pathway))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C3892](http://purl.obolibrary.org/obo/NCIT_C3892) (Mu Heavy Chain Disease))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38850](http://purl.obolibrary.org/obo/NCIT_C38850) (Phosphatidylinositol Signaling System Pathway))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38834](http://purl.obolibrary.org/obo/NCIT_C38834) (MAPK Signaling Pathway))) 47.86%
- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) and (not ([NCIT:C38829](http://purl.obolibrary.org/obo/NCIT_C38829) (Focal Adhesion Pathway))) 47.86%


